
Billing & Coding: What to Know About New Category III CPT Codes for Digital Pathology
The new codes have garnered attention as a future mechanism for additional reimbursement and thus deserve further discussion.
Diagnostic Testing and Emerging Technologies
LAB COMPLIANCE ADVISOR
LABORATORY INDUSTRY REPORT
NATIONAL LAB REPORTER
The new codes have garnered attention as a future mechanism for additional reimbursement and thus deserve further discussion.
Last week’s three key cases included two involving drug testing that was either medically unnecessary, or not provided at all.
To avoid claims denials and improper billings, ensure billing and coding staff is aware of, and has adjusted to, all recent coding changes.
Recent case shows why failing to disclose to individuals the lab test list prices they may need to pay doesn’t count as consumer fraud.
Learn how your lab can effectively respond in these uncertain economic times to strengthen your competitive advantage and your bottom line.